_1777370220974_847775619.png&w=64&q=75){kind=small}
AI cancer treatments delayed due to chip shortage
Rene Haas, CEO of UK-based chip designer Arm Holdings, stated that artificial intelligence will eventually enable the discovery of a cancer cure beyond current human capabilities, though progress is limited by a chip shortage affecting data center development. Haas also predicted widespread use of humanoid robots within five years, but doubted UK manufacturing of chips will occur due to high costs and resource needs. He emphasized the importance of data quality in medical AI and noted Arm’s significant role in powering AI infrastructure worldwide.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)